1 row is stored for this page
Field Field type Value generic String Solifenacin brand String Vesicare structure File classes List of String , delimiter: , [[:Category:Antimuscarinics|Antimuscarinic (M3-selective)]] • [[:Category:Overactive_bladder_medications|Overactive bladder medication]] mechanism String '"`UNIQ--vote-00000DFA-QINU`"' CYP3A4 substrate; QT-interval prolongation has been reported at higher doses. Like other antimuscarinics, contributes to cumulative anticholinergic burden in older adults'"`UNIQ--ref-00000DFB-QINU`"'. uses String '"`UNIQ--vote-00000DFC-QINU`"', '"`UNIQ--vote-00000DFD-QINU`"' starting_dose String 5 mg PO once daily; titrate to 10 mg after 2 weeks if needed preparations String 5, 10 mg tablets fda_max String 10 mg/d (5 mg if severe renal or moderate hepatic impairment, or strong CYP3A4 inhibitors) pill_id Text routes List of String , delimiter: , Oral onset String Symptom improvement within 1-2 weeks duration String 24 hours halflife String ~45-68 hours'"`UNIQ--ref-00000DFE-QINU`"' bioavailability String ~90% (oral)'"`UNIQ--ref-00000DFF-QINU`"' pregnancy String Limited data.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> legal String [[USLegal:Prescription only|Rx-only]] in US
